China Resources Pharmaceutical Group
3320.HK
#3521
Rank
$3.84 B
Marketcap
$0.61
Share price
-1.65%
Change (1 day)
-11.38%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2024: $35.30 Billion USD

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is $35.30 Billion USD. In 2024 the company made a revenue of $35.30 Billion USD an increase over the revenue in the year 2023 that were of $34.61 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2023 to 2024

Annual revenue

Year Revenue Change
2024$35.30 B1.99%
2023$34.61 B